Epix Expanded Agreement With Cystic Fibrosis Foundation Valued At $50 Million
This article was originally published in The Pink Sheet Daily
Executive Summary
Extended deal includes potential for $37.7 million in payments to Epix, which is developing 3-D model of key protein associated with CF.